The Role of Pulsed Dye Laser Therapy in the Management of Burn Scars
Launched by UNIVERSITY OF MANITOBA · Dec 7, 2011
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how effective pulsed dye laser therapy is for treating burn scars. The researchers want to see if this treatment can help improve the height, texture, redness, and flexibility of scars that form after an acute burn injury. If you or someone you know has a burn scar that is between one to six months old, lives in Winnipeg, and has skin types I to III (which are lighter skin tones), you might be eligible to participate in this study.
Participants in the trial will receive laser treatment and will be monitored for any changes in their scars. It’s important to note that those with open wounds, active infections, or previous treatments for their scars (like steroid injections) will not be able to join. This study is currently recruiting participants, so if you're interested or want to learn more, please reach out to the study team for more information.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • burn scar
- • living in Winnipeg
- • scar age one to 6 months
- • Fitzpatrick I-III skin type
- Exclusion Criteria:
- • open wound
- • active infection
- • previous scar treatment with steroid injection or interferon
- • established disposition towards keloid scarring
About University Of Manitoba
The University of Manitoba, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive expertise in medical research, public health, and community engagement to conduct rigorous and ethical clinical studies. The institution aims to translate scientific findings into practical applications that enhance patient care and improve health outcomes. Committed to fostering a culture of excellence and integrity, the University of Manitoba prioritizes participant safety and scientific validity in all its clinical research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winnipeg, Manitoba, Canada
Patients applied
Trial Officials
S Logsetty, MD
Principal Investigator
University of Manitoba
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials